Italian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancy
- PMID: 40699541
- PMCID: PMC12518491
- DOI: 10.1007/s40618-025-02652-y
Italian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancy
Abstract
Aim: The present guideline (GL) is aimed to improve and standardize the treatment of primary hypothyroidism in non-pregnant adults and to offer all the patients the best possible care across the Italian country.
Target population: Non-pregnant adults with hypothyroidism.
Excluded population: This GL does not cover the treatment of hypothyroidism in children and adolescents under 18 years of age, in women who are pregnant or breastfeeding, nor in subjects with central hypothyroidism. Also patients who require suppressive therapy with levothyroxine after thyroidectomy for thyroid cancer and those with transient iatrogenic hypothyroidism were not considered in this GL.
Methods: The direct costs and the utilization of resources over time were evaluated for the implementation of the appropriate management within the National Health Service. Recommendations were based on the analysis, according to the GRADE methodology, of the evidence from literature. Patients preferences were collected and verified by means of specific bibliographic research and the active participation of two patients' representatives in the GL development group.
Results: The present GL provides 4 formal graded recommendations and 16 ungraded indications for good clinical practice. An elevated agreement was consistently obtained among the panel members.
Conclusions: The present GL provides operative recommendations-based on the best available evidence and cost-effectiveness analysis-for the treatment of adult patients with primary hypothyroidism. The expected benefits from the dissemination, application and implementation of this GL are the improvement of the quality of care, its homogenization across the national territory and the rationalization of health expenditure in the respect of patient preferences.
Keywords: Desiccated thyroid extracts; Hypothyroidism; Quality of life; Thyroid; Thyroxine; Triiodothyronine.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: CM was a recipient of a grant by IBSA. CV has been a consultant for IBSA and has been the scientific director in a CME course with non-conditioning funding by Merck. The other authors and the members of the panel declare no potential conflict of interest to be disclosed.
References
-
- Devdhar M, Ousman YH, Burman KD (2007) Hypothyroidism. Endocrinol Metab Clin North Am 36:595–615. 10.1016/j.ecl.2007.04.008 - PubMed
-
- Beck-Peccoz P, Rodari G, Giavoli C, Lania A (2017) Central hypothyroidism - a neglected thyroid disorder. Nat Rev Endocrinol 13:588–598. 10.1038/nrendo.2017.47 - PubMed
-
- Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC (2014) The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 99:923–931. 10.1210/jc.2013-2409 - PubMed
-
- Burch HB (2019) Drug effects on the thyroid. N Engl J Med 381:749–761. 10.1056/NEJMra1901214 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
